T

THERACELL ADVANCED BIOTECHNOLOGY (Belgium) (Private limited company)

BE 0731.712.273 Active ●Aye, Rue de la Science 8, 6900 Marche-en-Famenne

THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0731.712.273. It was founded on 30-07-2019. Its registered office is in Marche-en-Famenne. Its main activity is: Scientific research and development. Its annual accounts for 2022 report equity of € -179 076 and a loss of € 128 310. Addrly gives it a financial health grade of D, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2023 financial year have not been filed, although the legal deadline has passed.

Information last updated on 16-10-2026.

Company information

Status
Active
Enterprise number
BE 0731.712.273
VAT registered
Yes
Founded
30-07-2019
Latest accounts
2022
Employees
-
Region
Wallonia
Establishments
-
Filing record
2023 accounts not filed
Peppol e-invoicing
Not registered
Registered office
Aye, Rue de la Science 8, 6900 Marche-en-Famenne
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
72101 Recherche-développement en biotechnologie

Key figures of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)

20222021
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -128 310-92 %€ -66 861
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -179 076-253 %€ -50 765
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 327 833-28 %€ 456 860
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -37 200-273 %€ -9 979
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
--

Financial estimate

Financial health grade D, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Marche-en-Famenne.

CompanyTown
LARECO 6900 Marche-en-Famenne
ATB THERAPEUTICS 6900 Marche-en-Famenne
Orgenesis (Belgium) 6900 Marche-en-Famenne
RevaTis 6900 Marche-en-Famenne
MAP-S 6900 Marche-en-Famenne
AGRICELLS 6900 Marche-en-Famenne
VetDiag 6900 Marche-en-Famenne
LivingMed Biotech 6900 Marche-en-Famenne
Looking for more information about THERACELL ADVANCED BIOTECHNOLOGY (Belgium)?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is THERACELL ADVANCED BIOTECHNOLOGY (Belgium) still active? Yes. The Crossroads Bank for Enterprises lists THERACELL ADVANCED BIOTECHNOLOGY (Belgium) as active.

What is the VAT number of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)? The VAT number of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is BE 0731.712.273.

When was THERACELL ADVANCED BIOTECHNOLOGY (Belgium) founded? THERACELL ADVANCED BIOTECHNOLOGY (Belgium) was founded on 30-07-2019.

What is the address of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)? The current registered office of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is Aye, Rue de la Science 8, 6900 Marche-en-Famenne.

When did THERACELL ADVANCED BIOTECHNOLOGY (Belgium) last file annual accounts? The latest annual accounts of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) were filed on 14-07-2023.

Does THERACELL ADVANCED BIOTECHNOLOGY (Belgium) file its annual accounts on time? The annual accounts of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) for the 2023 financial year have not been filed, although the legal deadline has passed.

Is THERACELL ADVANCED BIOTECHNOLOGY (Belgium) financially healthy? Addrly gives THERACELL ADVANCED BIOTECHNOLOGY (Belgium) a financial health grade of D, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is THERACELL ADVANCED BIOTECHNOLOGY (Belgium) profitable? The annual accounts of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) for 2022 show a loss of € 128 310.

What is the equity of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)? The equity of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) was € -179 076 at the close of the 2022 financial year.

Who are the directors of THERACELL ADVANCED BIOTECHNOLOGY (Belgium)? The annual accounts of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) record 1 mandate. The name, role and dates are visible with a free account.

Can THERACELL ADVANCED BIOTECHNOLOGY (Belgium) receive Peppol e-invoices? THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is not registered on the Peppol network at the moment.

What does THERACELL ADVANCED BIOTECHNOLOGY (Belgium) do? The main activity of THERACELL ADVANCED BIOTECHNOLOGY (Belgium) is: Scientific research and development.

Sources

How Addrly builds and refreshes this data